Indexed keywords
AMYLASE;
ANTIRETROVIRUS AGENT;
SORAFENIB;
TRIACYLGLYCEROL LIPASE;
ABDOMINAL PAIN;
ACUTE PANCREATITIS;
ADULT;
CANCER PALLIATIVE THERAPY;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
DRUG INDUCED DISEASE;
DRUG WITHDRAWAL;
GALLSTONE FORMATION;
HEMATOCRIT;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
LIVER FUNCTION TEST;
MALE;
MEDICAL HISTORY;
PORTAL HYPERTENSION;
SHOCK;
ACUTE DISEASE;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, HEPATOCELLULAR;
HUMANS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
PANCREATITIS;
PYRIDINES;
1
47949116252
Sorafenib in advanced hepatocellular carcinoma
[PMID 18650514]
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359:378-90. [PMID 18650514]
(2008)
N Engl J Med , vol.359
, pp. 378-390
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
2
33744984843
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma
[PMID 16636341]
Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 2006; 24:2505-12. [PMID 16636341]
(2006)
J Clin Oncol , vol.24
, pp. 2505-2512
Ratain, M.J.1
Eisen, T.2
Stadler, W.M.3
Flaherty, K.T.4
Kaye, S.B.5
Rosner, G.L.6
3
34047233913
Sorafenib-induced pancreatitis
[PMID 17418082]
Amar S, Wu KJ, Tan WW. Sorafenib-induced pancreatitis. Mayo Clin Proc 2007; 82:521. [PMID 17418082]
(2007)
Mayo Clin Proc , vol.82
, pp. 521
Amar, S.1
Wu, K.J.2
Tan, W.W.3
4
34548448493
Acute pancreatitis associated with sorafenib
[PMID 17902294]
Li M, Srinivas S. Acute pancreatitis associated with sorafenib. South Med J 2007; 100:909-11. [PMID 17902294]
(2007)
South Med J , vol.100
, pp. 909-911
Li, M.1
Srinivas, S.2
5
33749170457
Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis
[PMID 17032204]
Banks PA, Freeman ML, Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101:2379-400. [PMID 17032204]
(2006)
Am J Gastroenterol , vol.101
, pp. 2379-2400
Banks, P.A.1
Freeman, M.L.2
6
34249712482
Drug-induced acute pancreatitis: An evidence-based review
[PMID 17395548]
Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5:648-61. [PMID 17395548]
(2007)
Clin Gastroenterol Hepatol , vol.5
, pp. 648-661
Badalov, N.1
Baradarian, R.2
Iswara, K.3
Li, J.4
Steinberg, W.5
Tenner, S.6
7
0028930571
American Society of Hospital Pharmacy
ASHP guidelines on adverse drug reaction monitoring and reporting, [PMID 7757870]
ASHP guidelines on adverse drug reaction monitoring and reporting. American Society of Hospital Pharmacy. Am J Health Syst Pharm 1995; 52:417-9. [PMID 7757870]
(1995)
Am J Health Syst Pharm , vol.52
, pp. 417-419
8
84897866536
Common Terminology Criteria for Adverse Events (CTCAE) v4.0
National Cancer Institute
National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v4.0. National Cancer Institute 2009. http://evs.nci.nih.gov/ftp1/CTCAE/About.html
(2009)
National Cancer Institute
